Urticarial vasculitis is a condition where hives (urticaria) are caused by inflammation of small blood vessels in the skin rather than by a simple allergic reaction. The key distinction: ordinary hives fade within a few hours, while urticarial vasculitis lesions persist for more than 24 hours, often leave behind faint brownish discoloration, and tend to burn or hurt rather than just itch. Estimates suggest that anywhere from 2% to 27% of people who show up with what looks like chronic hives actually have urticarial vasculitis, making it an underrecognized diagnosis.
How It Differs From Regular Hives
At first glance, urticarial vasculitis looks like ordinary hives: raised, reddish welts on the skin. But the similarities are mostly superficial. Regular hives are driven by the release of histamine and typically resolve within a few hours, moving from one spot to another. Urticarial vasculitis welts stick around for more than 24 hours in the same location because the underlying problem is damage to the walls of tiny blood vessels, not just histamine release.
The sensations are different too. In one clinical study, every patient reported both itching and burning, and nearly 88% also had pain and tenderness in the affected areas. That burning, painful quality is a red flag that separates urticarial vasculitis from garden-variety hives, which mostly just itch. After the lesions clear, about 12.5% of patients are left with patches of darker skin (residual hyperpigmentation), something that almost never happens with ordinary hives.
What Happens Under the Skin
The underlying process is a type of small-vessel vasculitis. Immune complexes (clumps of antibodies bound to their targets) deposit in the walls of small blood vessels, triggering inflammation. White blood cells swarm in, and their enzymes damage the vessel walls. Blood leaks out of the damaged vessels into the surrounding tissue, which is why the welts can look purplish and why discoloration sometimes lingers.
A skin biopsy is the only way to confirm the diagnosis. Pathologists look for three hallmark features: fragments of destroyed white blood cells (leukocytoclasia), fibrin deposits clogging the inside of small vessels, and red blood cells that have escaped into the surrounding tissue. Ideally, the biopsy is taken from a lesion that appeared less than 24 hours earlier, because older lesions can lose some of these telltale signs.
Two Subtypes With Very Different Outlooks
Once urticarial vasculitis is confirmed, blood tests for complement proteins (C3, C4, and C1q) divide patients into two groups that behave quite differently.
Normocomplementemic urticarial vasculitis (NUV) means complement levels are normal. This is the milder form. About 30% of NUV patients develop joint or muscle aches, and kidney involvement is uncommon, occurring in roughly 5% of cases. Most people with NUV deal primarily with skin symptoms.
Hypocomplementemic urticarial vasculitis (HUV) means complement levels are low, indicating a more aggressive immune process. Nearly 80% of HUV patients experience joint pain and muscle aches, and true joint inflammation (arthritis) shows up in over 40%. Kidney problems, such as protein or blood in the urine from inflamed filtering units in the kidneys, affect about 24% of HUV patients. The most severe form, sometimes called HUV syndrome or McDuffie syndrome, involves multiple organ systems and requires close monitoring.
Links to Lupus and Other Autoimmune Conditions
Hypocomplementemic urticarial vasculitis has a well-documented overlap with systemic lupus erythematosus (SLE). About 7 to 8% of people with lupus have HUV, and the relationship runs the other direction too: up to 54% of people diagnosed with HUV eventually develop lupus during follow-up. The two conditions share joint pain, skin involvement, and low complement levels, which can make telling them apart genuinely difficult, even for specialists.
This overlap is the main reason doctors order a thorough panel of blood work after a biopsy confirms urticarial vasculitis. Beyond complement levels, the standard workup includes a complete blood count, kidney function tests, urinalysis, liver function tests, and screening for hepatitis B and C. In HUV specifically, antibodies against C1q (a complement protein) are found in virtually 100% of patients and serve as a useful marker. These same antibodies appear in 30 to 48% of lupus patients, further illustrating how intertwined the two conditions can be.
What Treatment Looks Like
Treatment depends on severity. For mild cases limited to the skin, antihistamines and anti-inflammatory pain relievers are the starting point. They won’t always clear lesions completely, since the underlying problem isn’t purely histamine-driven, but they can reduce discomfort.
When flares are intermittent, short courses of oral corticosteroids (steroids taken by mouth for days to weeks) can tamp down inflammation quickly. The challenge is that symptoms often return once steroids are tapered, so doctors try to avoid long-term use because of cumulative side effects like bone thinning and weight gain.
For people whose skin symptoms keep coming back or who have the hypocomplementemic form, three medications show effectiveness comparable to steroids with fewer long-term risks: hydroxychloroquine (originally an antimalarial drug), colchicine (commonly used for gout), and dapsone (an older antibiotic with strong anti-inflammatory properties). These are often the backbone of ongoing treatment.
If those options aren’t enough, stronger immune-suppressing medications may be considered. In especially resistant cases, newer biologic therapies that target specific parts of the immune system have shown promise, though evidence is still building. People with organ involvement, particularly kidney disease, typically need more aggressive treatment and closer follow-up.
Living With Urticarial Vasculitis
The day-to-day experience varies widely depending on the subtype. People with normocomplementemic urticarial vasculitis often have a course limited to recurring, painful welts that are frustrating but manageable. Flares may come and go over months or years, and some people eventually go into remission.
For those with the hypocomplementemic form, ongoing monitoring matters. Periodic blood work to check complement levels, kidney function, and inflammatory markers helps catch organ involvement early. Because of the strong link to lupus, doctors will often reassess for lupus-related symptoms over time, even if the initial workup was negative. Joint pain, fatigue, mouth sores, or a facial rash developing after an HUV diagnosis warrants prompt attention, since these can signal that lupus has entered the picture.